Cathay Biotech Inc. News

Cathay Biotech (688065): Three-quarter report improves performance and opens up application space for new bio-based materials

shanghai SecuritiesNov 14 00:00

Kaiser Biotech (688065): Q3 performance is in line with expected continuous release of sebacic acid

huaan SecuritiesNov 3 18:07

Kaisai Biotech (688065) Annual Report Review: Sebacic Acid Release Drives Performance Growth Bio-based Nylon Cooperation is progressing smoothly

Aug 19 20:41

Kaisai Biotech (688065) 2024 Interim Report Review: 24Q2 Month-on-month Growth Continues Steady Progress in China Merchants Cooperation

Aug 19 11:11

Kaisai Biotech (688065) review: Q2 performance continued month-on-month repair, steady progress in commercialization of bio-based composites

Aug 18 00:00

Kaisai Biotech (688065): Promoting R&D investment and capacity building to accumulate growth momentum

May 14 19:56

Cathay Biotech (688065): Q1 main business performance inflection point, actively developing bio-based polyamide and piperidine businesses

May 12 00:00

Cathay Biotech (688065): Demand recovery in 24Q1 is optimistic about capacity release+strategic cooperation to drive growth

May 7 00:00

Kaiser Biotech (688065): Demand is under pressure in 2023 24Q1 demand will improve significantly, and there is plenty of space for bio-based polyamides

May 6 07:51

Kaisai Biotech (688065) 2023 Annual Report and 2024 Quarterly Report Review: Q1 long-chain dibasic acid sales increased, profit increased significantly year-on-year

May 5 00:00

Kaisai Biotech (688065): 24Q1 performance, year-on-month recovery in demand for long-chain binary acid recovery

May 1 11:36

Kaiser Biotech (688065): Significant increase in first-quarter results, imminent release of bio-based polyamides

Apr 30 18:36

Cathay Biotech (688065): Demand for long-chain binary acids is picking up, Q1 performance is high year-on-month, and bio-based composites accelerate commercial application implementation

Apr 30 13:16

Kaisai Biotech (688065): Q1 performance increased significantly over the same period last month and continued to advance

Apr 23 00:00

Kaisai Biotech (688065) 24Q1 performance pre-increase review: 24Q1 gradually progresses towards positive fixed growth projects

Apr 15 00:00

Cathay Biotech (688065): Demand for long-chain binary acids is picking up, looking forward to commercial application of bio-based composites

Apr 14 00:00

Kaisai Biotech (688065) Review: Performance is under pressure due to declining demand for long-chain binary acids, waiting for commercial application of bio-based composites to be implemented

Feb 25 00:00

Kaisai Biotech (688065): Constant increase and continuous promotion of bio-based nylon have broad prospects

Dec 21, 2023 09:46

Kaisai Biotech (688065): Long-chain binary acid production continues to expand, China Merchants bureau's equity investment helps promote the application of bio-based polyamides

Dec 5, 2023 19:42

Kaisai Biotech (688065): Long-chain binary acid gross profit is declining, performance is under pressure, and the application prospects for bio-based composites are broad

Nov 16, 2023 00:00